2023 Consulting Patient-Centered Provider 
Today's Hospitalist
MAY 9, 2025
Since the mid-1990s, our capacity for innovation has never stopped as hospitalists navigate a complex landscape of acute illnesses, interprofessional collaborations and the imperative to provide efficient, high-quality care. Beyond time savings, ambient AI can enhance the quality of our patient interactions. The result?
The Clinical Problem Solvers
MARCH 14, 2025
Her mission — preparing the next generation of diverse physician leaders in pediatric healthcare and mental health and creating partnerships between communities and academic centers — will be critical for eliminating disparities among minority populations. A Culturally Informed Approach to Supporting Suicidal Minoritized Patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
MAY 18, 2025
Robotic nurses dressing mannequins and bed-bathing patients Delicate movement, like gently handling an elderly patient is traditionally the most challenging task to robots, who are much faster developing in intellectual tasks than matching humans in fine-motor skills. Since then, the concept has become a reality.
FDA Law Blog
SEPTEMBER 20, 2021
When FDA published the fiscal years (FY) 2023-2027 goals letter at the end of August, making known their commitments and planned initiatives for the coming years, we were both excited by many of the announcements, while recognizing the real success will come from how the Agency implements them.
FDA Law Blog
NOVEMBER 6, 2024
Starting in 2022 with a patent certification requirement, both Jazz and Avadel have sued FDA over this drug, with Jazz most recently bringing suit challenging FDA’s decision that Avadel’s Lumryz (sodium oxybate) is clinically superior to Jazz’s Xywav (sodium oxybate) in 2023.
The Clinical Problem Solvers
APRIL 24, 2025
Her mission — preparing the next generation of diverse physician leaders in pediatric healthcare and mental health and creating partnerships between communities and academic centers — will be critical for eliminating disparities among minority populations. A Culturally Informed Approach to Supporting Suicidal Minoritized Patients.
FDA Law Blog
APRIL 23, 2023
This Draft Guidance focuses on the use of patient-level data from other clinical trials or from RWD sources. The goal is to select similar patients in the treatment and external control groups. The Draft Guidance also states that sponsors must include in their marketing applications relevant patient-level data for both arms.
Expert insights. Personalized for you.
52 
Let's personalize your content